{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T16:09:49Z","timestamp":1748275789582},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,5]]},"DOI":"10.7759\/cureus.41401","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T13:23:32Z","timestamp":1688563412000},"source":"Crossref","is-referenced-by-count":1,"title":["Viscoelastometry to Manage Bleeding in Liver Disease"],"prefix":"10.7759","author":[{"given":"Samantha","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Danta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J","family":"Rabbolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21303","article-title":"Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management","volume":"44","author":"Caldwell SH","year":"2006","unstructured":"Caldwell SH, Hoffman M, Lisman T, et al.. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006, 44:1039-46. 10.1002\/hep.21303","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i35.10062","article-title":"Coagulopathy in liver disease: lack of an assessment tool","volume":"21","author":"Blasi A","year":"2015","unstructured":"Blasi A. Coagulopathy in liver disease: lack of an assessment tool. World J Gastroenterol. 2015, 21:10062-71. 10.3748\/wjg.v21.i35.10062","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1550434","article-title":"Clinical utility of viscoelastic tests of coagulation (TEG\/ROTEM) in patients with liver disease and during liver transplantation","volume":"41","author":"Mallett SV","year":"2015","unstructured":"Mallett SV. Clinical utility of viscoelastic tests of coagulation (TEG\/ROTEM) in patients with liver disease and during liver transplantation. Semin Thromb Hemost. 2015, 41:527-37. 10.1055\/s-0035-1550434","journal-title":"Semin Thromb Hemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230613","article-title":"High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia","volume":"23","author":"Ferro D","year":"1996","unstructured":"Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology. 1996, 23:1377-83. 10.1002\/hep.510230613","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80104-4","article-title":"Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels","volume":"30","author":"Albornoz L","year":"1999","unstructured":"Albornoz L, Alvarez D, Otaso JC, et al.. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol. 1999, 30:451-5. 10.1016\/s0168-8278(99)80104-4","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman T","year":"2006","unstructured":"Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006, 44:53-61. 10.1002\/hep.21231","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108773","article-title":"Dysfibrinogenemia associated with liver disease","volume":"60","author":"Palascak JE","year":"1977","unstructured":"Palascak JE, Martinez J. Dysfibrinogenemia associated with liver disease. J Clin Invest. 1977, 60:89-95. 10.1172\/JCI108773","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V61.6.1196.1196","article-title":"The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains","volume":"61","author":"Martinez J","year":"1983","unstructured":"Martinez J, MacDonald KA, Palascak JE. The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains. Blood. 1983, 61:1196-202. 10.1182\/blood.V61.6.1196.1196","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.08.045","article-title":"An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis","volume":"137","author":"Tripodi A","year":"2009","unstructured":"Tripodi A, Primignani M, Chantarangkul V, et al.. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology. 2009, 137:2105-11. 10.1053\/j.gastro.2009.08.045","journal-title":"Gastroenterology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1550437","article-title":"The fibrinolytic status in liver diseases","volume":"41","author":"Leebeek FW","year":"2015","unstructured":"Leebeek FW, Rijken DC. The fibrinolytic status in liver diseases. Semin Thromb Hemost. 2015, 41:474-80. 10.1055\/s-0035-1550437","journal-title":"Semin Thromb Hemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03299.x","article-title":"Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease","volume":"95","author":"Agarwal S","year":"2000","unstructured":"Agarwal S, Joyner KA Jr, Swaim MW. Ascites fluid as a possible origin for hyperfibrinolysis in advanced liver disease. Am J Gastroenterol. 2000, 95:3218-24. 10.1111\/j.1572-0241.2000.03299.x","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman T","year":"2010","unstructured":"Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010, 116:878-85. 10.1182\/blood-2010-02-261891","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i14.1818","article-title":"Spontaneous bleeding or thrombosis in cirrhosis: what should be feared the most?","volume":"7","author":"Rodr\u00edguez-Castro KI","year":"2015","unstructured":"Rodr\u00edguez-Castro KI, Antonello A, Ferrarese A. Spontaneous bleeding or thrombosis in cirrhosis: what should be feared the most?. World J Hepatol. 2015, 7:1818-27. 10.4254\/wjh.v7.i14.1818","journal-title":"World J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01881.x","article-title":"The prothrombin time-derived international normalized ratio: great for warfarin, fair for prognosis and bad for liver-bleeding risk","volume":"28","author":"Caldwell S","year":"2008","unstructured":"Caldwell S, Shah N. The prothrombin time-derived international normalized ratio: great for warfarin, fair for prognosis and bad for liver-bleeding risk. Liver Int. 2008, 28:1325-7. 10.1111\/j.1478-3231.2008.01881.x","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000103655","article-title":"Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment","volume":"24","author":"Lisman T","year":"2007","unstructured":"Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007, 24:250-8. 10.1159\/000103655","journal-title":"Dig Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03369.x","article-title":"Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease","volume":"26","author":"Tripodi A","year":"2007","unstructured":"Tripodi A, Caldwell SH, Hoffman M, Trotter JF, Sanyal AJ. Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther. 2007, 26:141-8. 10.1111\/j.1365-2036.2007.03369.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21732","article-title":"The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation","volume":"46","author":"Tripodi A","year":"2007","unstructured":"Tripodi A, Chantarangkul V, Primignani M, Fabris F, Dell'Era A, Sei C, Mannucci PM. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology. 2007, 46:520-7. 10.1002\/hep.21732","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318168fcd4","article-title":"Coagulation defects do not predict blood product requirements during liver transplantation","volume":"85","author":"Massicotte L","year":"2008","unstructured":"Massicotte L, Beaulieu D, Thibeault L, Roy JD, Marleau D, Lapointe R, Roy A. Coagulation defects do not predict blood product requirements during liver transplantation. Transplantation. 2008, 85:956-62. 10.1097\/TP.0b013e318168fcd4","journal-title":"Transplantation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181a5e5f1","article-title":"MELD score and blood product requirements during liver transplantation: no link","volume":"87","author":"Massicotte L","year":"2009","unstructured":"Massicotte L, Beaulieu D, Roy JD, et al.. MELD score and blood product requirements during liver transplantation: no link. Transplantation. 2009, 87:1689-94. 10.1097\/TP.0b013e3181a5e5f1","journal-title":"Transplantation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181aed477","article-title":"Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation","volume":"88","author":"Massicotte L","year":"2009","unstructured":"Massicotte L, Capitanio U, Beaulieu D, Roy JD, Roy A, Karakiewicz PI. Independent validation of a model predicting the need for packed red blood cell transfusion at liver transplantation. Transplantation. 2009, 88:386-91. 10.1097\/TP.0b013e3181aed477","journal-title":"Transplantation"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.06.020","article-title":"Evaluation of coagulation abnormalities in acute liver failure","volume":"57","author":"Agarwal B","year":"2012","unstructured":"Agarwal B, Wright G, Gatt A, et al.. Evaluation of coagulation abnormalities in acute liver failure. J Hepatol. 2012, 57:780-6. 10.1016\/j.jhep.2012.06.020","journal-title":"J Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00546.x","article-title":"Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review","volume":"45","author":"Segal JB","year":"2005","unstructured":"Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion. 2005, 45:1413-25. 10.1111\/j.1537-2995.2005.00546.x","journal-title":"Transfusion"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/cld.528","article-title":"Assessing the risk of bleeding and clotting in cirrhosis","volume":"7","author":"Shah NL","year":"2016","unstructured":"Shah NL, Caldwell SH. Assessing the risk of bleeding and clotting in cirrhosis. Clin Liver Dis (Hoboken). 2016, 7:26-8. 10.1002\/cld.528","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical practice update: coagulation in cirrhosis","volume":"157","author":"O'Leary JG","year":"2019","unstructured":"O'Leary JG, Greenberg CS, Patton HM, Caldwell SH. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology. 2019, 157:34-43.e1. 10.1053\/j.gastro.2019.03.070","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup PG","year":"2021","unstructured":"Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al.. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 73:366-413. 10.1002\/hep.31646","journal-title":"Hepatology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","unstructured":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol. 2022, 76.1151-84. 10.1016\/j.jhep.2021.09.003","journal-title":"J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02122.x","article-title":"No evidence for an intrinsic platelet defect in patients with liver cirrhosis--studies under flow conditions","volume":"4","author":"Lisman T","year":"2006","unstructured":"Lisman T, Adelmeijer J, de Groot PG, Janssen HL, Leebeek FW. No evidence for an intrinsic platelet defect in patients with liver cirrhosis--studies under flow conditions. J Thromb Haemost. 2006, 4:2070-2. 10.1111\/j.1538-7836.2006.02122.x","journal-title":"J Thromb Haemost"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/BF01313579","article-title":"Bleeding after liver biopsy does not correlate with indices of peripheral coagulation","volume":"26","author":"Ewe K","year":"1981","unstructured":"Ewe K. Bleeding after liver biopsy does not correlate with indices of peripheral coagulation. Dig Dis Sci. 1981, 26:388-93. 10.1007\/BF01313579","journal-title":"Dig Dis Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.04.019","article-title":"A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation","volume":"7","author":"Vieira da Rocha EC","year":"2009","unstructured":"Vieira da Rocha EC, D'Amico EA, Caldwell SH, et al.. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol. 2009, 7:988-93. 10.1016\/j.cgh.2009.04.019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2018.09.043","article-title":"AGA clinical practice update on surgical risk assessment\u00a0and perioperative management in cirrhosis: expert review","volume":"17","author":"Northup PG","year":"2019","unstructured":"Northup PG, Friedman LS, Kamath PS. AGA clinical practice update on surgical risk assessment\u00a0and perioperative management in cirrhosis: expert review. Clin Gastroenterol Hepatol. 2019, 17:595-606. 10.1016\/j.cgh.2018.09.043","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.11.015","article-title":"Incidence and risk factors for adverse events related to image-guided liver biopsy","volume":"91","author":"Boyum JH","year":"2016","unstructured":"Boyum JH, Atwell TD, Schmit GD, Poterucha JJ, Schleck CD, Harmsen WS, Kamath PS. Incidence and risk factors for adverse events related to image-guided liver biopsy. Mayo Clin Proc. 2016, 91:329-35. 10.1016\/j.mayocp.2015.11.015","journal-title":"Mayo Clin Proc"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12792","article-title":"Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele P","year":"2015","unstructured":"Gresele P. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2015, 13:314-22. 10.1111\/jth.12792","journal-title":"J Thromb Haemost"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1728786","article-title":"The current role of platelet function testing in clinical practice","volume":"47","author":"Mason GA","year":"2021","unstructured":"Mason GA, Rabbolini DJ. The current role of platelet function testing in clinical practice. Semin Thromb Hemost. 2021, 47:843-54. 10.1055\/s-0041-1728786","journal-title":"Semin Thromb Hemost"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08793.x","article-title":"Guidelines for the laboratory investigation of heritable disorders of platelet function","volume":"155","author":"Harrison P","year":"2011","unstructured":"Harrison P, Mackie I, Mumford A, Briggs C, Liesner R, Winter M, Machin S. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011, 155:30-44. 10.1111\/j.1365-2141.2011.08793.x","journal-title":"Br J Haematol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12231","article-title":"Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the Platelet Physiology Subcommittee of SSC\/ISTH","author":"Cattaneo M","year":"2013","unstructured":"Cattaneo M, Cerletti C, Harrison P, et al.. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the Platelet Physiology Subcommittee of SSC\/ISTH. J Thromb Haemost. 2013, 10.1111\/jth.12231","journal-title":"J Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.06.008","article-title":"Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?","volume":"55","author":"Violi F","year":"2011","unstructured":"Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?. J Hepatol. 2011, 55:1415-27. 10.1016\/j.jhep.2011.06.008","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.08.013","article-title":"Platelet function in patients with cirrhosis","volume":"56","author":"Lisman T","year":"2012","unstructured":"Lisman T, Porte RJ. Platelet function in patients with cirrhosis. J Hepatol. 2012, 56:993-4; author reply 994-5. 10.1016\/j.jhep.2011.08.013","journal-title":"J Hepatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5049.144657","article-title":"Coagulation testing in the perioperative period","volume":"58","author":"Thiruvenkatarajan V","year":"2014","unstructured":"Thiruvenkatarajan V, Pruett A, Adhikary SD. Coagulation testing in the perioperative period. Indian J Anaesth. 2014, 58:565-72. 10.4103\/0019-5049.144657","journal-title":"Indian J Anaesth"},{"key":"ref39","unstructured":"Haemoview Diagnostics. ClotPro. (2021). Accessed: September 19, 2021: https:\/\/www.haemoview.com.au\/clotprointerpretation."},{"key":"ref40","unstructured":"Hemosonics. Cartridges. (2021). Accessed: September 19, 2021: https:\/\/hemosonics.com\/cartridges\/."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01413-w","article-title":"Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and non-ACLF patients","volume":"20","author":"See\u00dfle J","year":"2020","unstructured":"See\u00dfle J, L\u00f6hr J, Kirchner M, Michaelis J, Merle U. Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and non-ACLF patients. BMC Gastroenterol. 2020, 20:271. 10.1186\/s12876-020-01413-w","journal-title":"BMC Gastroenterol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aex122","article-title":"Assessment of standard laboratory tests and rotational thromboelastometry for the prediction of postoperative bleeding in liver transplantation","volume":"119","author":"D\u00f6tsch TM","year":"2017","unstructured":"D\u00f6tsch TM, Dirkmann D, Bezinover D, Hartmann M, Treckmann JW, Paul A, Saner FH. Assessment of standard laboratory tests and rotational thromboelastometry for the prediction of postoperative bleeding in liver transplantation. Br J Anaesth. 2017, 119:402-10. 10.1093\/bja\/aex122","journal-title":"Br J Anaesth"},{"key":"ref43","article-title":"The role of rotational thromboelastometry in early prediction of bleeding esophageal varices in patients with advanced cirrhosis","volume":"30","author":"El-Makarem M","year":"2019","unstructured":"El-Makarem M, Afifi O, El-Fattah A, Mohammad A. The role of rotational thromboelastometry in early prediction of bleeding esophageal varices in patients with advanced cirrhosis. Malaysian J Med Res. 2019, 30:227-32.","journal-title":"Malaysian J Med Res"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts LN","year":"2022","unstructured":"Roberts LN, Lisman T, Stanworth S, Hernandez-Gea V, Magnusson M, Tripodi A, Thachil J. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH. J Thromb Haemost. 2022, 20:39-47. 10.1111\/jth.15562","journal-title":"J Thromb Haemost"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/cld.947","article-title":"Thromboelastography and utility in hepatology practice","volume":"16","author":"Shenoy A","year":"2020","unstructured":"Shenoy A, Intagliata NM. Thromboelastography and utility in hepatology practice. Clin Liver Dis (Hoboken). 2020, 16:149-52. 10.1002\/cld.947","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.05.144","article-title":"Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial","volume":"42","author":"Wang SC","year":"2010","unstructured":"Wang SC, Shieh JF, Chang KY, et al.. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010, 42:2590-3. 10.1016\/j.transproceed.2010.05.144","journal-title":"Transplant Proc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2015.04.022","article-title":"Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome","volume":"446","author":"Leon-Justel A","year":"2015","unstructured":"Leon-Justel A, Noval-Padillo JA, Alvarez-Rios AI, et al.. Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome. Clin Chim Acta. 2015, 446:277-83. 10.1016\/j.cca.2015.04.022","journal-title":"Clin Chim Acta"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-018-0664-8","article-title":"Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study","volume":"18","author":"Zamper RP","year":"2018","unstructured":"Zamper RP, Amorim TC, Queiroz VN, et al.. Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study. BMC Anesthesiol. 2018, 18:198. 10.1186\/s12871-018-0664-8","journal-title":"BMC Anesthesiol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.egja.2018.03.004","article-title":"Rotational thormboelastolmetry guided transfusion practice in living donor liver transplantation, a retrospective comparative study","volume":"34","author":"Kandeel A-R","year":"2018","unstructured":"Kandeel A-R, Abdalla U, Abouelella M, Elmorshedi M, Elsarraf W, Abdelwahab M, Yassen A. Rotational thormboelastolmetry guided transfusion practice in living donor liver transplantation, a retrospective comparative study. Egyptian J Anaesth. 2018, 34:55-9. 10.1016\/j.egja.2018.03.004","journal-title":"Egyptian J Anaesth"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004014","article-title":"Consensus statement on hemostatic management, anticoagulation, and antiplatelet therapy in liver transplantation","volume":"106","author":"Montalv\u00e1 E","year":"2022","unstructured":"Montalv\u00e1 E, Rodr\u00edguez-Per\u00e1lvarez M, Blasi A, et al.. Consensus statement on hemostatic management, anticoagulation, and antiplatelet therapy in liver transplantation. Transplantation. 2022, 106:1123-31. 10.1097\/TP.0000000000004014","journal-title":"Transplantation"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28148","article-title":"Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial","volume":"63","author":"De Pietri L","year":"2016","unstructured":"De Pietri L, Bianchini M, Montalti R, et al.. Thrombelastography-guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: a randomized, controlled trial. Hepatology. 2016, 63:566-73. 10.1002\/hep.28148","journal-title":"Hepatology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05939-2","article-title":"A randomized control trial of thromboelastography-guided transfusion in cirrhosis for high-risk invasive liver-related procedures","volume":"65","author":"Vuyyuru SK","year":"2020","unstructured":"Vuyyuru SK, Singh AD, Gamanagatti SR, Rout G, Gunjan D, Shalimar. A randomized control trial of thromboelastography-guided transfusion in cirrhosis for high-risk invasive liver-related procedures. Dig Dis Sci. 2020, 65:2104-11. 10.1007\/s10620-019-05939-2","journal-title":"Dig Dis Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14672","article-title":"Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: a randomized controlled trial","volume":"18","author":"Rocha LL","year":"2020","unstructured":"Rocha LL, Neto AS, Pessoa CM, et al.. Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: a randomized controlled trial. J Thromb Haemost. 2020, 18:560-70. 10.1111\/jth.14672","journal-title":"J Thromb Haemost"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001214","article-title":"Thromboelastography-guided blood product transfusion in cirrhosis patients with variceal bleeding: a randomized controlled trial","volume":"54","author":"Rout G","year":"2020","unstructured":"Rout G, Shalimar, Gunjan D, Mahapatra SJ, Kedia S, Garg PK, Nayak B. Thromboelastography-guided blood product transfusion in cirrhosis patients with variceal bleeding: a randomized controlled trial. J Clin Gastroenterol. 2020, 54:255-62. 10.1097\/MCG.0000000000001214","journal-title":"J Clin Gastroenterol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30794","article-title":"Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial","volume":"71","author":"Kumar M","year":"2020","unstructured":"Kumar M, Ahmad J, Maiwall R, et al.. Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: a randomized controlled trial. Hepatology. 2020, 71:235-46. 10.1002\/hep.30794","journal-title":"Hepatology"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001588","article-title":"Thromboelastography versus standard coagulation testing in the assessment and reversal of coagulopathy among cirrhotics: a systematic review and meta-analysis","volume":"32","author":"Kovalic AJ","year":"2020","unstructured":"Kovalic AJ, Khan MA, Malaver D, et al.. Thromboelastography versus standard coagulation testing in the assessment and reversal of coagulopathy among cirrhotics: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2020, 32:291-302. 10.1097\/MEG.0000000000001588","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0549-2","article-title":"Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery","volume":"18","author":"Hincker A","year":"2014","unstructured":"Hincker A, Feit J, Sladen RN, Wagener G. Rotational thromboelastometry predicts thromboembolic complications after major non-cardiac surgery. Crit Care. 2014, 18:549. 10.1186\/s13054-014-0549-2","journal-title":"Crit Care"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12992","article-title":"Use of viscoelastic tests to predict clinical thromboembolic events: a systematic review and meta-analysis","volume":"100","author":"Harahsheh Y","year":"2018","unstructured":"Harahsheh Y, Ho KM. Use of viscoelastic tests to predict clinical thromboembolic events: a systematic review and meta-analysis. Eur J Haematol. 2018, 100:113-23. 10.1111\/ejh.12992","journal-title":"Eur J Haematol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001395","article-title":"Preoperative thromboelastography as a sensitive tool predicting those at risk of developing early hepatic artery thrombosis after adult liver transplantation","volume":"100","author":"Zahr Eldeen F","year":"2016","unstructured":"Zahr Eldeen F, Roll GR, Derosas C, et al.. Preoperative thromboelastography as a sensitive tool predicting those at risk of developing early hepatic artery thrombosis after adult liver transplantation. Transplantation. 2016, 100:2382-90. 10.1097\/TP.0000000000001395","journal-title":"Transplantation"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23668","article-title":"Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography","volume":"19","author":"Krzanicki D","year":"2013","unstructured":"Krzanicki D, Sugavanam A, Mallett S. Intraoperative hypercoagulability during liver transplantation as demonstrated by thromboelastography. Liver Transpl. 2013, 19:852-61. 10.1002\/lt.23668","journal-title":"Liver Transpl"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155847-viscoelastometry-to-manage-bleeding-in-liver-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:35Z","timestamp":1707508895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155847-viscoelastometry-to-manage-bleeding-in-liver-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.41401","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,5]]}}}